India should introduce a new Drugs Act.
نویسندگان
چکیده
www.thelancet.com Vol 383 January 18, 2014 203 This report results from research funded by the European Union Seventh Framework Programme Theme: Health-2009-4.3.2-2 (Grant no. 242262) under the title Access to Medicines in Africa and South Asia (AMASA). The project team includes partners at the Swiss Tropical and Public Health Institute at the University of Basel (Switzerland), University of Edinburgh (UK), Queen Mary, University of London (UK), University of Ghent (Belgium), Makerere University (Uganda) Mbarara University of Science and Technology (Uganda), University of the Western Cape (South Africa), and the Foundation for Research in Community Health (India). India should introduce a new Drugs Act
منابع مشابه
Comparison of Price regarding the Domesticly Produced Medicine with the Price of the Similar Generic Medicine in India
Background: Supporting domestic production, by assuming its effect on the increase of accessibility, has been acknowledged as one of the main pharmaceutical policies from two dimensions of better provision of the drugs in the market and the increase of affordability by reducing prices. Therefore, it is expected from the domestic industries to produce pharmaceutical products that, in addition to...
متن کاملA comparative study on the effects of new opioid compounds and morphine on the contractility of guinea pig ileum and mouse vas deferens
Considering the clinical significance of opioids, especially their application for the treatment of severe painful conditions including cancer pain and the requirement for the synthesis of more specific drugs with lower side effects, this study was conducted to perform a preliminary investigation on six newly developed opioid drugs. Our aim was to introduce drugs that act selectively on the opi...
متن کاملDraft Amendment to Drugs and Cosmetics Rules to License Science Based Botanicals, Phytopharmaceuticals as Drugs in India
The Government of India has published a draft amendment to Drugs and Cosmetics Act, and Rules (D&C Act and Rules) on 24th October 2013.[1] This creates regulatory provisions of defi ning phytopharmaceuticals (botanicalbased drugs) and a schedule providing requirements of scientifi c data on quality, safety, and effi cacy to evaluate and marketing authorization for a plant-based lead as a drug o...
متن کاملErosion of Trust in the Medical Profession in India: Time for Doctors to Act
In India, over the last decade, a series of stewardship failures in the health system, particularly in the medical profession, have led to a massive erosion of trust in these institutions. In many low- and middle-income countries (LMICs), the situation is similar and has reached crisis proportions; this crisis requires urgent attention. This paper draws on the insights from the recent developme...
متن کاملIndia combats confusion over counterfeit drugs.
India, the leading supplier of low-cost generic drugs to Africa, has begun fi ghting back to counter the confusion surrounding counterfeit drugs in the region. A raft of new and proposed anti-counterfeit laws could potentially deprive Africa of aff ordable, essential medicines. The immediate cause of concern is Kenya’s Anti-Counterfeit Act 2008, which came into eff ect in July, 2009. The new la...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Lancet
دوره 383 9913 شماره
صفحات -
تاریخ انتشار 2014